Randomized study on the effectiveness of nomegestrol acetate plus 17β-estradiol oral contraceptive versus dienogest oral pill in women with suspected endometriosis‑associated chronic pelvic pain
Abstract Background To evaluate the effects of a combined oral contraceptive containing 1.5 mg 17b-estradiol (E2) and 2.5 mg nomegestrol acetate (NOMAC) or 2 mg/daily dienogest (DNG) oral progestin on endometriosis-associated chronic pelvic pain (CPP) and on the quality of life (QoL) and sexual func...
Saved in:
Main Authors: | Salvatore Caruso (Author), Antonio Cianci (Author), Marco Iraci Sareri (Author), Marco Panella (Author), Giuseppe Caruso (Author), Stefano Cianci (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2022-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Nomegestrol acetate/17-beta estradiol: a review of efficacy, safety, and patient acceptability
by: Akintomide H, et al.
Published: (2015) -
Nomegestrol acetate - a new progestogen for oral contraception (a review)
by: V N Prilepskaya, et al.
Published: (2015) -
Estradiol valerate and dienogest: a new approach to oral contraception
by: Kiley JW, et al.
Published: (2011) -
Endometrial safety of an oral contraceptive containing estradiol valerate and dienogest
by: Bitzer J, et al.
Published: (2011) -
Review of the safety, efficacy and patient acceptability of the combined dienogest/estradiol valerate contraceptive pill
by: Maurizio Guida, et al.
Published: (2010)